Human Tumor Antigens Are Ready to Fly

This publication has 100 references indexed in Scilit:

• Human Immune Response to DNP-Modified Autologous Cells after Treatment with a DNP-Conjugated Melanoma Vaccine
  Clinical Immunology and Immunopathology, 1995
• Characterization of natural peptide ligands for HLA‐B*4402 and ‐B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA‐B44 heavy chain
  Tissue Antigens, 1994
• Structure, chromosomal localization, and expression of 12 genes of the MAGE family
  Immunogenetics, 1994
• Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant
  Cancer Immunology, Immunotherapy, 1993
• Evaluation of human carcinoembryonic-antigen (CEA)-transduced and non-transduced murine tumors as potential targets for anti-CEA therapies
  Cancer Immunology, Immunotherapy, 1993
• Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene: Effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human MUC1 gene
  Cancer Immunology, Immunotherapy, 1993
• Emergence of Idiotype Variants during Treatment of B-Cell Lymphoma with Anti-Idiotype Antibodies
  New England Journal of Medicine, 1985
• Gangliosides of normal and neoplastic human melanocytes
  Biochemical and Biophysical Research Communications, 1984
• A pigmentation‐associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum
  International Journal of Cancer, 1983
• Prostate antigen: A new potential marker for prostatic cancer
  The Prostate, 1981